Shu Dong

Shanghai Medical College of Fudan University — China

Medicine · Health Sciences

25h-index2.1kcitations95works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(14), Liver Disease Diagnosis and Treatment(14), Cancer Immunotherapy and Biomarkers(8), Hepatitis B Virus Studies(7), Liver physiology and pathology(7)

Publications95 total

Retrospective analysis of the curative effect of Kanglaite injection on pancreatic cancer
Journal of Medical Biochemistry·2025Open Access
Development of leptospiral virulence-modifying protein detection assay: implications for pathogenesis and diagnostic test development
Microbiology Spectrum·2025Open Access
Combination immunotherapy in hepatocellular carcinoma: synergies among immune checkpoints, TKIs, and chemotherapy
Journal of Hematology & Oncology·2025· 9 citedOpen Access
1380P Establishment and validation of a recursive partitioning analysis prognosis model to identify beneficiaries of metronomic capecitabine adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
Annals of Oncology·2025
Response rates, survival status and adverse events of placebo in randomized control trials for hepatocellular carcinoma: A meta-analysis
World Journal of Hepatology·2025Open Access
Research on the Impact of Delayed Retirement Policy on the Labor-market Under the Background of Population Aging
Transactions on Social Science Education and Humanities Research·2025Open Access
Effects of FAP<sup>+</sup> cancer-associated fibroblasts on anti-PD-1 immunotherapy and CD4<sup>+</sup> T cell polarization in gastric cancer
Cancer Drug Resistance·2025· 3 citedOpen Access
Impact of sociodemographic factors and baseline health insurance coverage on 1-year outcomes following bariatric surgery
Metabolism and Target Organ Damage·2025Open Access
Camrelizumab combined with cetuximab and chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): 1-year outcomes from the phase II trial.
Journal of Clinical Oncology·2025
SHR-A1811 in HER2-expressing salivary gland cancers: Preliminary efficacy and safety results.
Journal of Clinical Oncology·2025· 2 cited
Retlirafusp alfa-a bifunctional anti-PD-L1/TGF-βRII agent plus nab-paclitaxel and carboplatin in pre-treated recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC): A prospective, single-arm, phase II clinical trial.
Journal of Clinical Oncology·2025· 1 cited
Population pharmacokinetics and dose evaluation for second-line TB drugs in patients with diabetes
The International Journal of Tuberculosis and Lung Disease·2025
Target-driven Attack for Large Language Models
Frontiers in artificial intelligence and applications·2024· 3 citedOpen Access
Insights on Chinese and European consensus for USgHIFU treatment of pancreatic cancer
HepatoBiliary Surgery and Nutrition·2024Open Access
Retraction Notice to: Circular RNA circFOXM1 Plays a Role in Papillary Thyroid Carcinoma by Sponging miR-1179 and Regulating HMGB1 Expression
Molecular Therapy — Nucleic Acids·2024Open Access
When AI Meets Finance (StockAgent): Large Language Model-based Stock Trading in Simulated Real-world Environments
arXiv (Cornell University)·2024· 3 citedOpen Access
Associations between PM2.5 and its chemical constituents and blood pressure: a cross-sectional study
Journal of Hypertension·2024· 6 cited
Preliminary efficacy and safety of camrelizumab combined with cetuximab and chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): A phase II clinical trial.
Journal of Clinical Oncology·2024· 1 cited
A phase II umbrella clinical trial of advanced salivary gland cancer based on molecular typing.
Journal of Clinical Oncology·2024· 3 cited
A Multitrait Locus Regulates Sarbecovirus Pathogenesis
UNC Libraries·2024Open Access
page 1 of 5Next →

Frequent Co-authors

Shi-Bing Su(10), Qilong Chen(7), Ping Liu(7), Zhiqiang Meng(7), Yanan Song(6), David F. Clayton(5), Zhen Chen(5), Lei Wang(5), Yiyang Hu(4), Mingyu Sun(4), Hongyan Cao(4), Yanqin Bian(4), Qiwen Chen(4), Lanyun Feng(4), Zhouyu Ning(4), Yongqiang Hua(4), Chien‐shan Cheng(4), Yi-Yu Lu(4), Bin Wei(3), Kirstin Replogle(3)